Governors Lane’s Nuvation Bio NUVB Stock Holding History

Governors Lane’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-293,900	Closed	-$3.29M	–	136
2020 Q3	$3.29M	Buy	+293,900	New	+$3.17M	0.3%	66

Other funds holding NUVB

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Governors Lane's NUVB Position: Q4 2020 in Review

Governors Lane sold out of Nuvation Bio (NUVB) in Q4 2020, closing a stake of 293,900 shares — an estimated $3.29M sold.

Governors Lane first reported a position in NUVB in Q3 2020 and held it in 1 quarter. The position peaked at $3.29M in Q3 2020. 33 funds tracked by Wall St. Rank hold NUVB as of Q4 2020.

Governors Lane reported no remaining Nuvation Bio position as of Q4 2020 after selling out during the quarter.
Governors Lane sold 293,900 Nuvation Bio shares in Q4 2020, an estimated $3.29M.
Governors Lane first reported a position in Nuvation Bio in Q3 2020 and held it in 1 quarter.
Governors Lane's Nuvation Bio position peaked at $3.29M in Q3 2020.
33 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2020.

Based on Governors Lane's 13F filing for Q4 2020, filed 16 Feb 2021.